Kim Sablich - Net Worth and Insider Trading

Kim Sablich Net Worth

The estimated net worth of Kim Sablich is at least $5 Million dollars as of 2024-03-19. Kim Sablich is the EVP, GM of U.S., Commercial Ma of Jazz Pharmaceuticals PLC and owns about 30,560 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $4 Million. Kim Sablich is also the Chief Commercial Officer of Myovant Sciences Ltd and owns about 58,905 shares of Myovant Sciences Ltd (MYOV) stock worth over $2 Million. Details can be seen in Kim Sablich's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kim Sablich has not made any transactions after 2023-03-08 and currently still holds the listed stock(s).

Transaction Summary of Kim Sablich

To

Kim Sablich Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kim Sablich owns 3 companies in total, including Jazz Pharmaceuticals PLC () , Myovant Sciences Ltd () , and Eiger BioPharmaceuticals Inc () .

Click here to see the complete history of Kim Sablich’s form 4 insider trades.

Insider Ownership Summary of Kim Sablich

Ticker Comapny Transaction Date Type of Owner
Jazz Pharmaceuticals PLC 2023-03-08 EVP & GM & North America
Myovant Sciences Ltd 2020-03-18 Chief Commercial Officer
Eiger BioPharmaceuticals Inc 2022-03-11 director

Kim Sablich Latest Holdings Summary

Kim Sablich currently owns a total of 2 stocks. Among these stocks, Kim Sablich owns 30,560 shares of Jazz Pharmaceuticals PLC (JAZZ) as of March 8, 2023, with a value of $4 Million and a weighting of 70.35%. Kim Sablich also owns 58,905 shares of Myovant Sciences Ltd (MYOV) as of March 18, 2020, with a value of $2 Million and a weighting of 29.65%.

Latest Holdings of Kim Sablich

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
JAZZ Jazz Pharmaceuticals PLC 2023-03-08 30,560 123.41 3,771,410
MYOV Myovant Sciences Ltd 2020-03-18 58,905 26.98 1,589,257

Holding Weightings of Kim Sablich


Kim Sablich Form 4 Trading Tracker

According to the SEC Form 4 filings, Kim Sablich has made a total of 3 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 3,013 shares on March 8, 2023, which brought Kim Sablich around $421,037.

According to the SEC Form 4 filings, Kim Sablich has made a total of 3 transactions in Myovant Sciences Ltd (MYOV) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Myovant Sciences Ltd is the sale of 785 shares on March 18, 2020, which brought Kim Sablich around $5,785.

Insider Trading History of Kim Sablich

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kim Sablich Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kim Sablich Ownership Network

Ownership Network List of Kim Sablich

No Data

Ownership Network Relation of Kim Sablich


Kim Sablich Owned Company Details

What does Jazz Pharmaceuticals PLC do?

Who are the key executives at Jazz Pharmaceuticals PLC?

Kim Sablich is the EVP & GM & North America of Jazz Pharmaceuticals PLC. Other key executives at Jazz Pharmaceuticals PLC include VP & Finance& PAO Patricia Carr , SVP & General Counsel Neena M Patil , and director & 10 percent owner Patrick G Enright .

Jazz Pharmaceuticals PLC () Insider Trades Summary

Over the past 18 months, Kim Sablich made no insider transaction in Jazz Pharmaceuticals PLC (). Other recent insider transactions involving Jazz Pharmaceuticals PLC () include a net sale of 6,364 shares made by Patricia Carr , a net sale of 52,185 shares made by Bruce C Cozadd , and a net sale of 7,360 shares made by Neena M Patil .

In summary, during the past 3 months, insiders sold 3,704 shares of Jazz Pharmaceuticals PLC () in total and bought 12,000 shares, with a net purchase of 8,296 shares. During the past 18 months, 109,886 shares of Jazz Pharmaceuticals PLC () were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 97,886 shares.

Jazz Pharmaceuticals PLC ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Jazz Pharmaceuticals PLC Insider Transactions

No Available Data

Kim Sablich Mailing Address

Above is the net worth, insider trading, and ownership report for Kim Sablich. You might contact Kim Sablich via mailing address: C/o Myovant Sciences Inc., 2000 Sierra Point Parkway, Brisbane Ca 94005.

Discussions on Kim Sablich

No discussions yet.